Vertex Pharmaceuticals (VRTX) Other Non Operating Income (2012 - 2025)

Vertex Pharmaceuticals (VRTX) has reported Other Non Operating Income for 14 consecutive years, with $6.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non Operating Income rose 143.62% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $9.9 million (up 113.66% YoY), while the FY2025 annual figure was -$7.7 million, up 91.06% from the prior year.
• Other Non Operating Income came in at $6.5 million for Q4 2025 at Vertex Pharmaceuticals, up from -$9.8 million in the prior quarter.
• The five-year high for Other Non Operating Income was $42.4 million in Q3 2021, with the low at -$78.1 million in Q2 2022.
• Average Other Non Operating Income over 5 years is -$13.8 million, with a median of -$12.4 million recorded in 2023.
• Across the five-year window, Other Non Operating Income sank 2500.0% in 2024 and surged 157.14% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $7.1 million in 2021, then slumped by 538.03% to -$31.1 million in 2022, then surged by 68.49% to -$9.8 million in 2023, then sank by 52.04% to -$14.9 million in 2024, then surged by 143.62% to $6.5 million in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $6.5 million, -$9.8 million, and $13.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.